ALISO VIEJO, Calif., July 26, 2007 (PRIME NEWSWIRE) -- SenoRx, Inc. (Nasdaq:SENO) today announced that Lloyd Malchow, President and Chief Executive Officer, will present at the Canaccord Adams Global Growth Conference on Thursday, August 9, 2007 at the InterContinental Hotel in Boston, Massachusetts. The company is scheduled to present at 9:00 a.m. EST.
SenoRx invites investors and those interested to listen to a live webcast of this presentation via the Internet on the Investor Relations section of the company's Web site www.senorx.com. A webcast replay of the presentation will be available on company's website and will be archived for approximately 30 days.
About SenoRx
SenoRx (Nasdaq:SENO), which completed its initial public offering of common stock in March 2007, develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis of breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 17 products that have already received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605